Michael J. Birrer
Impact in
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Papers in
-
- Ovarian cancer diagnosis and treatment 115
-
- Cancer Genomics and Diagnostics 47
- Cancer-related molecular mechanisms research 25
- Co-authors
- Samuel C. Mok (35 shared papers)Gini F. Fleming (16 shared papers)Bradley Monk (17 shared papers)Kathleen N. Moore (28 shared papers)Robert S. Mannel (11 shared papers)Mark F. Brady (9 shared papers)John Dorrance Minna (15 shared papers)Anil K. Sood (11 shared papers)
- Journals
- Gynecologic Oncology (75 papers)Clinical Cancer Research (20 papers)Annals of Oncology (18 papers)Cell (17 papers)Cancer Research (17 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Michael J. Birrer
462 papers receiving 65.4k citations
Michael J. Birrer's Hit Papers
Peers
Comparison fields: 5 of 183
- Reproductive Medicine 10.3k
- Cancer Research 16.7k
- Oncology 19.0k
- Molecular Biology 31.9k
- Obstetrics and Gynecology 2.4k
Countries citing papers authored by Michael J. Birrer
This map shows the geographic impact of Michael J. Birrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Birrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Birrer more than expected).
Fields of papers citing papers by Michael J. Birrer
This network shows the impact of papers produced by Michael J. Birrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Birrer. The network helps show where Michael J. Birrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Birrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 470 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Integrated genomic analyses of ovarian carcinoma Hit paper breakdown → | 2011 | 6345 |
| 2 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 3 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 4 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 5 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 6 | Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer Hit paper breakdown → | 2011 | 1914 |
| 7 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 8 | Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis Hit paper breakdown → | 1996 | 1664 |
| 9 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 10 | Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1394 |
| 11 | p53: A Frequent Target for Genetic Abnormalities in Lung Cancer Hit paper breakdown → | 1989 | 1096 |
| 12 | BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group Hit paper breakdown → | 2012 | 974 |
| 13 | Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Hit paper breakdown → | 2015 | 915 |
| 14 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 15 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 16 | Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 Hit paper breakdown → | 1991 | 725 |
| 17 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 18 | Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study Hit paper breakdown → | 2019 | 634 |
| 19 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 606 |
| 20 | Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer Hit paper breakdown → | 2008 | 590 |
About Michael J. Birrer
Michael J. Birrer is a scholar working on Reproductive Medicine, Cancer Research, Oncology, Molecular Biology and Obstetrics and Gynecology, having authored 470 papers that have together received 66.6k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (115 papers), Cancer Genomics and Diagnostics (47 papers), RNA modifications and cancer (36 papers), PARP inhibition in cancer therapy (32 papers), Cancer-related Molecular Pathways (31 papers), Cancer-related molecular mechanisms research (25 papers), Ubiquitin and proteasome pathways (22 papers) and RNA Research and Splicing (22 papers). The work is most often cited by research in Reproductive Medicine (10.3k citations), Cancer Research (16.7k citations), Oncology (19.0k citations), Molecular Biology (31.9k citations) and Obstetrics and Gynecology (2.4k citations). Michael J. Birrer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Samuel C. Mok, Gini F. Fleming, Bradley Monk, Kathleen N. Moore, Robert S. Mannel, Mark F. Brady, John Dorrance Minna, Anil K. Sood, Robert Allen Burger and Michael A. Bookman. Their work appears in journals such as Gynecologic Oncology, Clinical Cancer Research, Annals of Oncology, Cell and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.